- Home
- / GB Sciences
GB Sciences
Stock Price
$0
2024-10-29
Market Capitalization
$40.7 K
2024-10-29
Revenue
$3.1 M
FY, 2020
GB Sciences Summary
Company Summary
- Overview
- GB Sciences is a company that converts the cannabis plant into medicines, therapies, and treatments for a variety of ailments. It produces consistent and measurable medical-grade cannabis, cannabis concentrates, and cannabinoid therapies.
- Type
- Public
- Status
- Active
- Founded
- 2001
- HQ
- Las Vegas, NV, US | view all locations
- Website
- https://gbsciences.com/
- Cybersecurity rating
Table of Contents
Key People
Andrea Small-Howard, Chief Science Officer
Michael Farley, Executive VP of Corporate Development, GBS Global Biopharma
Monica Poss, VP of Corporate Planning
LocationsView all
2 locations detected
Las Vegas, NV HQ
United States
3550 W Teco Ave
Ottawa, ON
Canada
900 Morrison Dr #200
GB Sciences Financials
Summary Financials
- Revenue (Q3, 2025)
- $97.2K
- Cash (Q3, 2025)
- $3.0K
- Enterprise value
- $2.6M